Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-17
DOI
10.3389/fonc.2019.01514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma
- (2019) Katelynn Davis et al. PLoS One
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
- (2019) Cristina Travelli et al. CANCER RESEARCH
- Nicotinamide Phosphoribosyl Transferase Is Increased in Osteosarcomas and Chondrosarcomas Compared to Benign Bone and Cartilage
- (2019) ANDREW T. MERAM et al. ANTICANCER RESEARCH
- FOXO1 functions in the regulation of nicotinamide phosphoribosyltransferase (Nampt) expression
- (2019) Bora Jeong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Epigenetic regulation of NAMPT by NAMPT-AS drives metastatic progression in triple-negative breast cancer
- (2019) Hanwen Zhang et al. CANCER RESEARCH
- NAMPT regulates PKM2 nuclear location through 14‐3‐3ζ: Conferring resistance to tamoxifen in breast cancer
- (2019) Xin Ge et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
- (2019) Sudhir Chowdhry et al. NATURE
- Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies
- (2019) Yi Zhu et al. PHARMACOLOGY & THERAPEUTICS
- Screening common signaling pathways associated with drug resistance in non‐small cell lung cancer via gene expression profile analysis
- (2019) Ting Sun et al. Cancer Medicine
- NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
- (2019) Antonio Lucena-Cacace et al. Frontiers in Oncology
- NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer
- (2019) Xiao-qin Li et al. Frontiers in Oncology
- Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling
- (2019) Hongxia Liu et al. Aging-US
- Inhibition of NAMPT markedly enhances plasma-activated medium-induced cell death in human breast cancer MDA-MB-231 cells
- (2019) Misaki Nagaya et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Exogenous pyruvate represses histone gene expression and inhibits cancer cell proliferation via the NAMPT–NAD+–SIRT1 pathway
- (2019) Rui Ma et al. NUCLEIC ACIDS RESEARCH
- PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma
- (2019) Nathan R. Fons et al. Nature Communications
- Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis
- (2019) Lydia Brandl et al. NEOPLASIA
- PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors
- (2019) Gabriel Mpilla et al. Cancers
- High expression of NAMPT in adult T-cell leukemia/lymphoma and anti-tumor activity of a NAMPT inhibitor
- (2019) Tomohiro Kozako et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent
- (2019) Anne-Julie Cloux et al. Oncotarget
- Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype
- (2018) Mickaël Ohanna et al. GENES & DEVELOPMENT
- DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
- (2018) Mehdi Touat et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of NAMPT sensitizes MOLT4 leukemia cells for etoposide treatment through the SIRT2-p53 pathway
- (2018) Theresa Grohmann et al. LEUKEMIA RESEARCH
- The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges
- (2018) Maria Dalamaga et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition
- (2018) Weixuan Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis
- (2018) Shao‑Jie Zhou et al. Oncology Letters
- Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma
- (2018) Valentina Audrito et al. Oncotarget
- NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils
- (2018) Ekaterina Pylaeva et al. INTERNATIONAL JOURNAL OF CANCER
- Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer
- (2018) Jing-hua Pan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD+Pools
- (2018) Jeffrey P. Chmielewski et al. MOLECULAR CANCER RESEARCH
- EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
- (2018) Aparna Gorthi et al. NATURE
- Genotype-targeted local therapy of glioma
- (2018) Ganesh M. Shankar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis
- (2018) J. Patrick Murphy et al. Cell Reports
- IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
- (2018) Elisa Bergaggio et al. BLOOD
- Increased Nicotinamide adenine dinucleotide pool promotes colon cancer progression by suppressing reactive oxygen species level
- (2018) Sun M. Hong et al. CANCER SCIENCE
- Genomic and tumor biological aspects of the anticancer nicotinamide phosphoribosyltransferase inhibitor FK866 in resistant human colorectal cancer cells
- (2018) Yoko Ogino et al. GENOMICS
- The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target
- (2018) Lydia Brandl et al. MEDICAL ONCOLOGY
- FK866 inhibits the epithelial‑mesenchymal transition of hepatocarcinoma MHCC97‑H cells
- (2018) Bin Zhang et al. Oncology Letters
- Loss of the Chr16p11.2 ASD candidate gene QPRT leads to aberrant neuronal differentiation in the SH-SY5Y neuronal cell model
- (2018) Denise Haslinger et al. Molecular Autism
- NAD Metabolism in Cancer Therapeutics
- (2018) Keisuke Yaku et al. Frontiers in Oncology
- Rho GTPase effectors and NAD metabolism in cancer immune suppression
- (2017) Mahmoud Chaker et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration
- (2017) Genshi Zhao et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress
- (2017) Renhua Xu et al. ONCOLOGY REPORTS
- Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells
- (2017) Zafar Gholinejad et al. PEPTIDES
- Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma
- (2017) Xin Yue Wang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells
- (2017) Cornelia N. Mutz et al. Oncotarget
- Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
- (2017) Jair Machado Espindola-Netto et al. Oncotarget
- NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis
- (2017) Antonio Lucena-Cacace et al. Oncotarget
- Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy
- (2017) Jonathan Cole et al. Oncotarget
- Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
- (2017) Valentina Audrito et al. JNCI-Journal of the National Cancer Institute
- Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
- (2017) Haijun Li et al. Journal of Immunology Research
- A phase 1 trial of GMX1777: An inhibitor of nicotinamide phosphoribosyl transferase (NAMPRT)
- (2017) M. J. Pishvaian et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagic homeostasis is required for the pluripotency of cancer stem cells
- (2016) Tanveer Sharif et al. Autophagy
- Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
- (2016) Huai-Qiang Ju et al. CANCER LETTERS
- Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
- (2016) K. Tateishi et al. CLINICAL CANCER RESEARCH
- Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenstro m Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status
- (2016) M. Cea et al. CLINICAL CANCER RESEARCH
- Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities
- (2016) Hang Chen et al. Expert Review of Anticancer Therapy
- Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth
- (2016) O. Abu Aboud et al. MOLECULAR CANCER THERAPEUTICS
- An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma
- (2016) Amit D. Gujar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT
- (2016) Marine Barraud et al. Oncotarget
- Cytoplasmic proliferating cell nuclear antigen connects glycolysis and cell survival in acute myeloid leukemia
- (2016) Delphine Ohayon et al. Scientific Reports
- Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway
- (2016) Jun Feng et al. Biomed Research International
- Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma
- (2016) Simone M. Goldinger et al. JAMA Dermatology
- Nicotinamide Phosphoribosyltransferase and SirT3 Expression are increased in Well-Differentiated Thyroid Carcinomas
- (2016) Rodney Shackelford et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable
- (2016) Yang Xiao et al. PLoS One
- FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells
- (2015) Susanne Schuster et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combinative effects of β-Lapachone and APO866 on pancreatic cancer cell death through reactive oxygen species production and PARP-1 activation
- (2015) Caroline S. Breton et al. BIOCHIMIE
- EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition
- (2015) Chiara Zucal et al. BMC CANCER
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- The NAD+ salvage pathway modulates cancer cell viability via p73
- (2015) T Sharif et al. CELL DEATH AND DIFFERENTIATION
- APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia Cells
- (2015) A. Cagnetta et al. CLINICAL CANCER RESEARCH
- Dedifferentiation of cancer cells following recovery from a potentially lethal damage is mediated by H2S–Nampt
- (2015) Elena A. Ostrakhovitch et al. EXPERIMENTAL CELL RESEARCH
- Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells
- (2015) Bo Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Physiological and pathophysiological roles of NAMPT and NAD metabolism
- (2015) Antje Garten et al. Nature Reviews Endocrinology
- NAMPT suppresses glucose deprivation-induced oxidative stress by increasing NADPH levels in breast cancer
- (2015) S M Hong et al. ONCOGENE
- Biomarker triplet NAMPT/VEGF/HER2 as a de novo detection panel for the diagnosis and prognosis of human breast cancer
- (2015) YANYAN ZHU et al. ONCOLOGY REPORTS
- Visfatin promotes osteosarcoma cell migration and invasion via induction of epithelial-mesenchymal transition
- (2015) GONG CHENG et al. ONCOLOGY REPORTS
- Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
- (2015) Deepak Sampath et al. PHARMACOLOGY & THERAPEUTICS
- Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma
- (2015) Ambra A. Grolla et al. Pigment Cell & Melanoma Research
- Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression
- (2015) Nadia Sawicka-Gutaj et al. TUMOR BIOLOGY
- NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone
- (2015) Z Moore et al. Cell Death & Disease
- Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors
- (2015) Sara Duarte-Pereira et al. Oncotarget
- Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer
- (2015) Xiaoqun Lv et al. Journal of Cancer
- Dependence of Tumor Cell Lines and Patient-Derived Tumors on the NAD Salvage Pathway Renders Them Sensitive to NAMPT Inhibition with GNE-618
- (2015) Yang Xiao et al. NEOPLASIA
- Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
- (2014) Valentina Audrito et al. BLOOD
- Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non-Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption
- (2014) M. Chan et al. CANCER RESEARCH
- BRCA1 as a nicotinamide adenine dinucleotide (NAD)-dependent metabolic switch in ovarian cancer
- (2014) Da Li et al. CELL CYCLE
- On-Target Effect of FK866, a Nicotinamide Phosphoribosyl Transferase Inhibitor, by Apoptosis-Mediated Death in Chronic Lymphocytic Leukemia Cells
- (2014) I. Gehrke et al. CLINICAL CANCER RESEARCH
- Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer
- (2014) Antonio F. Santidrian et al. DNA REPAIR
- Nicotinamide Phosphoribosyltransferase Promotes Epithelial-to-Mesenchymal Transition as a Soluble Factor Independent of Its Enzymatic Activity
- (2014) Debora Soncini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolomics Analysis of Metabolic Effects of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on Human Cancer Cells
- (2014) Vladimir Tolstikov et al. PLoS One
- NAD+ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo study
- (2014) Shuraila F. Zerp et al. RADIOTHERAPY AND ONCOLOGY
- NAD+ and sirtuins in aging and disease
- (2014) Shin-ichiro Imai et al. TRENDS IN CELL BIOLOGY
- NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples
- (2014) Sara Duarte-Pereira et al. Scientific Reports
- Intracellular NAD(H) levels control motility and invasion of glioma cells
- (2013) Remco van Horssen et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors
- (2013) D. S. Shames et al. CLINICAL CANCER RESEARCH
- Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors
- (2013) C. C. S. Chini et al. CLINICAL CANCER RESEARCH
- Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience
- (2013) By Fabrizio Montecucco et al. CURRENT DRUG TARGETS
- NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity
- (2013) Sathisha Upparahalli Venkateshaiah et al. EXPERIMENTAL HEMATOLOGY
- De-Repression of PDGFRβ Transcription Promotes Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Glioblastoma Patients
- (2013) David Akhavan et al. Cancer Discovery
- Intracellular NAD+depletion induces autophagic death in multiple myeloma cells
- (2012) Michele Cea et al. Autophagy
- Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition
- (2012) M. Cea et al. BLOOD
- Nampt/Visfatin/PBEF: A Functionally Multi-faceted Protein with a Pivotal Role in Malignant Tumors
- (2012) He Jieyu et al. CURRENT PHARMACEUTICAL DESIGN
- Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
- (2012) Ilirjana Bajrami et al. EMBO Molecular Medicine
- Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells
- (2012) Basant Kumar Thakur et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT) Activity by Small Molecule GMX1778 Regulates Reactive Oxygen Species (ROS)-mediated Cytotoxicity in a p53- and Nicotinic Acid Phosphoribosyltransferase1 (NAPRT1)-dependent Manner
- (2012) David Cerna et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nicotinamide Phosphoribosyl Transferase (Nampt) Is Required for De Novo Lipogenesis in Tumor Cells
- (2012) Sarah C. Bowlby et al. PLoS One
- Nampt is involved in DNA double-strand break repair
- (2012) Bingtao Zhu et al. Chinese Journal of Cancer
- Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas
- (2011) UFFE HØGH OLESEN et al. APMIS
- Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase
- (2011) Li-Yuan Zhang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity
- (2011) Huei-Jiun Yang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation
- (2011) Shunsuke Okumura et al. Journal of Thoracic Oncology
- Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil
- (2011) Xiang-Ming Che ONCOLOGY REPORTS
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quinolinate phosphoribosyl transferase, a key enzyme in de novo NAD+ synthesis, suppresses spontaneous cell death by inhibiting overproduction of active-caspase-3
- (2010) Kazumi Ishidoh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells
- (2010) Gabriele Zoppoli et al. EXPERIMENTAL HEMATOLOGY
- A Preclinical Study on the Rescue of Normal Tissue by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase Inhibitor
- (2010) U. H. Olesen et al. MOLECULAR CANCER THERAPEUTICS
- NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response
- (2010) B Wang et al. ONCOGENE
- Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities
- (2009) Georg T. Wondrak ANTIOXIDANTS & REDOX SIGNALING
- SIRT1-dependent regulation of chromatin and transcription: Linking NAD+ metabolism and signaling to the control of cellular functions
- (2009) Tong Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study
- (2009) Nora Hinsch et al. BMC CANCER
- Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
- (2009) Anne von Heideman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Nicotinamide Phosphoribosyltransferase: A Molecular Link between Metabolism, Inflammation, and Cancer
- (2009) M. Galli et al. CANCER RESEARCH
- The Small Molecule GMX1778 Is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors
- (2009) M. Watson et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started